ClinicalTrials.gg

Tuberculosis clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 1,170 studies for Tuberculosis across more than 10 countries. 175 are recruiting or about to start. 766 of them are mainly about Tuberculosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 5 narrower conditions too, such as Tuberculosis, Pulmonary: 1,548 studies, 261 open.

ClinicalTrials.gov finds 1,672 studies for Tuberculosis. How that becomes 1,168 here

This page counts the studies the registry files under Tuberculosis, and those it files under no condition that list Tuberculosisthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,672Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −376Filed under a narrower condition, counted on its own pageTuberculosis, Pulmonary 183 · Latent Tuberculosis 100 · Tuberculosis, Multidrug-Resistant 62 · Tuberculosis, Meningeal 21
  3. −31List Tuberculosis as a condition, but the registry did not file them under itMost often written as “Mycobacterium Tuberculosis” (3), “Intestinal Tuberculosis” (3), and “Extrapulmonary Tuberculosis” (3). The registry filed 1 of them under no condition at all, and the others under other conditions only, most often Tuberculosis, Extrapulmonary (5) and Crohn Disease (3).
  4. −97Match it another way35 name it in the title, 10 in a keyword, and 52 by a synonym or other text the search reads.
  5. 1,168The count on this page23 of them list Tuberculosis in their own words; the registry filed them under no condition.

Status

Completed
747
Status unknown
143
Recruiting
111
Not yet recruiting
55
Terminated
41
Active, not recruiting
38

Phase

Phase 2
197
Phase 1
179
Phase 3
116
Phase 4
70
Early Phase 1
7

Where

South Africa
210
United States
129
Uganda
90
United Kingdom
65
India
64
China
62

Who develops what

Add Tuberculosis to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 16 programs from 10 companies, 12 with this as their studies’ main aim; 2 with a live phase 3 study; 1 primary completion in the next 12 months. Compare CanSino Biologics, Chongqing Zhifei Biological Products and PT Bio Farma here →

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
IsoniazidRecent, limited
Evidence
  • NCT07350174 · BioVersys AG · Phase 2 · live · comparator · “HRZE” · registered Jan 2026
  • NCT03334734 · Nearmedic Plus LLC · Phase 2 · comparator · “Isoniazid” · registered Nov 2017
GlaxoSmithKline25% of its industry studies11 study
RifampinRecent, limited
Evidence
  • NCT07350174 · BioVersys AG · Phase 2 · live · comparator · “HRZE” · registered Jan 2026
  • NCT03557281 · GlaxoSmithKline · Phase 2 · comparator · “Rifafour e-275” · registered Jun 2018
Bristol-Myers Squibb9% of its industry studies11 study
EthambutolRecent, limited
Evidence
  • NCT07350174 · BioVersys AG · Phase 2 · live · comparator · “HRZE” · registered Jan 2026
  • NCT03557281 · GlaxoSmithKline · Phase 2 · comparator · “Rifafour e-275” · registered Jun 2018
Pfizer43% of its industry studiesUS: off-patent, 2 generics marketed11 study

8 more in limited or earlier use — sign in to see them, free.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

In phase 3Company
5 unit(U) EC☆ Track1 live phase-3 study: NCT07152639Chengdu CoenBiotech Co., Ltd
5 IU TB-PPD☆ Track1 live phase-3 study: NCT07152639Chengdu CoenBiotech Co., Ltd

The 2 in phase 3 with the nearest primary completion, of 16 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (1)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • 7 Sept 2027 est.Vaccination with rBCG-N-RSV · Biothervax SpA · Phase 2 main aimNCT07762014 rBCG-N-RSV Vaccine in Adults Aged 60 Years and Older — primary endpoint: Occurrence, intensity, and duration of the local solicited AEs (evolution of the "flare-up") until the generation of the scar · 200 enrolled

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Tuberculosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Statins 3 open · Integrase inhibitors 2 open · Corticosteroids 1 open · Hormonal contraceptives 1 open · Reverse transcriptase inhibitors 18

Coming up

58studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 111 Tuberculosis studies recruiting now, 65 (59%) set no upper age limit and 36 (32%) stop at 75 or younger. 48 (43%) take children under 18. 3 (3%) are for women only and 2 (2%) for men only; 31 (28%) take healthy volunteers.

Recruiting studies that take each age, of 111
AgeWomenMen
1025 (23%)25 (23%)
1890 (81%)89 (80%)
3092 (83%)91 (82%)
4093 (84%)92 (83%)
5092 (83%)91 (82%)
6588 (79%)89 (80%)
7576 (68%)77 (69%)
8571 (64%)72 (65%)

Across all 1,170 studies, recruiting or not: 41% stop at 75 or younger and 38% at 65; 34% take children; 2% are for women only and 3% for men only; 34% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Tuberculosis studies take

Of 63 phase 2 interventional studies under Tuberculosis, half reached primary completion within 24 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 110 mo3–25 · 60 studies—13 mo3–30 · 40 studies
Phase 1/239 mo25–53 · 18 studies——
Phase 224 mo15–36 · 63 studies—24 mo15–37 · 43 studies
Phase 355 mo38–76 · 40 studies—54 mo38–67 · 33 studies
Phase 436 mo26–47 · 22 studies——
Interventional, no phase25 mo14–41 · 171 studies—25 mo15–41 · 169 studies
Observational36 mo21–76 · 135 studies—41 mo24–76 · 123 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 1,170. Browse all 1,170 → or search them.